AI assistant
Adicet Bio, Inc. — Director's Dealing 2021
Mar 19, 2021
34412_dirs_2021-03-18_09615171-fccf-476a-bc63-03395a0337c9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2021-03-16
Reporting Person: Schor Chen (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-16 | Common Stock | S | 6474 | $15.07 | Disposed | 155218 | Indirect |
| 2021-03-16 | Common Stock | S | 5395 | $15.66 | Disposed | 129318 | Indirect |
| 2021-03-16 | Common Stock | S | 2508 | $15.07 | Disposed | 152710 | Indirect |
| 2021-03-16 | Common Stock | S | 2089 | $15.66 | Disposed | 127229 | Indirect |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $14.49 to $15.48, inclusive.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $15.50 to $16.02, inclusive.
F4: Represents 152,710 shares held directly by an irrevocable family trust having an independent trustee.
F5: Represents 127,229 shares held directly by an irrevocable family trust having an independent trustee.